Ghent University Academic Bibliography

Your filters: cql: author="Marchesi, Francesco" or (type any "bookEditor issueEditor" and editor="Marchesi, Francesco")

Add to list
- Conference Paper
- C3
- open access
The CARV challenge : how do hematological malignancy patients struggle with diverse CARV pathogens

Jon Salmanton-Garcia, Francesco Marchesi, Jorge Labrador, Nicola Fracchiolla, Yavuz M Bilgin, Maria Ilaria Del Principe, Ľuboš Drgoňa, Laman Rahimli, Gaëtan Plantefève, Jens Van Praet (UGent) , et al.

(2025) OPEN FORUM INFECTIOUS DISEASES. In Open Forum Infectious Diseases 12(Supplement 1). p.S1334-S1334
Add to list
- Journal Article
- A1
- open access
Respiratory viruses in patients with hematological malignancy in boreal autumn/winter 2023–2024 : EPICOVIDEHA-EPIFLUEHA report

Jon Salmanton‐García, Francesco Marchesi, Milan Navrátil, Klára Piukovics, Maria Ilaria del Principe, Marianna Criscuolo, Yavuz M. Bilgin, Nicola S. Fracchiolla, Antonio Vena, Alessandra Romano, et al.

(2025) AMERICAN JOURNAL OF HEMATOLOGY. 100(3). p.358-374
Add to list
- Journal Article
- A1
- open access
Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic : results from the epicovideha registry

Pellegrino Musto, Jon Salmanton‐García, Nicola Sgherza, Rui Bergantim, Francesca Farina, Andreas Glenthøj, Guldane Cengiz Seval, Barbora Weinbergerová, Valentina Bonuomo, Yavuz M. Bilgin, et al.

(2024) HEMATOLOGICAL ONCOLOGY. 42(1).
Add to list
- Journal Article
- A1
- open access
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients : results from the EPICOVIDEHA registry

Tommaso Francesco Aiello, Jon Salmanton-Garcia, Francesco Marchesi, Barbora Weinbergerova, Andreas Glenthoj, Jens Van Praet (UGent) , Francesca Farina, Julio Davila-Valls, Sonia Martin-Perez, Shaimaa El-Ashwah, et al.

(2024) HAEMATOLOGICA. 109(8). p.2693-2700
Add to list
- Journal Article
- A1
- open access
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies : results from the EPICOVIDEHA survey

Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi, Shaimaa El-Ashwah, Marcio Nucci, Caroline Besson, Federico Itri, Ozren Jaksic, Natasha Čolović, Barbora Weinbergerová, et al.

(2024) INFECTION. 52(3). p.1125-1141
Add to list
- Journal Article
- A1
- open access
Decoding the historical tale : COVID-19 impact on haematological malignancy patients : EPICOVIDEHA insights from 2020 to 2022

Jon Salmanton-García, Francesco Marchesi, Francesca Farina, Barbora Weinbergerová, Federico Itri, Julio Dávila-Valls, Sonia Martín-Pérez, Andreas Glenthøj, Ditte Stampe Hersby, Maria Gomes Da Silva, et al.

(2024) ECLINICALMEDICINE. 71.
Add to list
- Journal Article
- A1
- open access
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19 : matched-paired analysis in the EPICOVIDEHA registry

Francesco Marchesi, Jon Salmanton-García, Caterina Buquicchio, Federico Itri, Caroline Besson, Julio Dávila-Valls, Sonia Martín-Pérez, Luana Fianchi, Laman Rahimli, Giuseppe Tarantini, et al.

(2023) JOURNAL OF HEMATOLOGY & ONCOLOGY. 16(1).
Add to list
- Journal Article
- A1
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post CD19-CAR-T : an EPICOVIDEHA survey

Jaap A. van Doesum, Jon Salmanton-García, Francesco Marchesi, Roberta Di Blasi, Iker Falces-Romero, Alba Cabirta, Francesca Farina, Caroline Besson, Barbora Weinbergerová, Jens Van Praet (UGent) , et al.

(2023) BLOOD ADVANCES. 7(11). p.2645-2655
Add to list
- Journal Article
- A1
- open access
Outcome of COVID-19 in allogeneic stem cell transplant recipients : results from the EPICOVIDEHA registry

Alessandro Busca, Jon Salmanton-García, Francesco Marchesi, Francesca Farina, Guldane Cengiz Seval, Jaap Van Doesum, Nick De Jonge, Nathan C. Bahr, Johan Maertens, Joseph Meletiadis, et al.

(2023) FRONTIERS IN IMMUNOLOGY. 14.
Add to list
- Journal Article
- A1
- open access
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe : a matched-paired analysis from the EPICOVIDEHA registry

Jon Salmanton-García, Francesco Marchesi, Philipp Koehler, Barbora Weinbergerová, Natasa Čolović, Iker Falces-Romero, Caterina Buquicchio, Francesca Farina, Jens Van Praet (UGent) , Monika M. Biernat, et al.

(2023) INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 62(4).

Academic Bibliography

The CARV challenge : how do hematological malignancy patients struggle with diverse CARV pathogens

Respiratory viruses in patients with hematological malignancy in boreal autumn/winter 2023–2024 : EPICOVIDEHA-EPIFLUEHA report

Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic : results from the epicovideha registry

Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients : results from the EPICOVIDEHA registry

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies : results from the EPICOVIDEHA survey

Decoding the historical tale : COVID-19 impact on haematological malignancy patients : EPICOVIDEHA insights from 2020 to 2022

Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19 : matched-paired analysis in the EPICOVIDEHA registry

Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post CD19-CAR-T : an EPICOVIDEHA survey

Outcome of COVID-19 in allogeneic stem cell transplant recipients : results from the EPICOVIDEHA registry

Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe : a matched-paired analysis from the EPICOVIDEHA registry

Contents

Support

Contact